Bangladesh approves Russia's Sputnik V coronavirus vaccine - RDIF
MOSCOW. April 27 (Interfax) - Bangladesh has officially approved Russia's Sputnik V coronavirus vaccine, the Russian Direct Investment Fund (RDIF) said on Tuesday.
"The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces that the Directorate General of Drug Administration (DGDA) under the Ministry of Health and Family Welfare of the People's Republic of Bangladesh has approved the use of the Russian Sputnik V vaccine against coronavirus," it said.
"The vaccine has been registered under the emergency use authorization procedure (EUA)," the RDIF said.
Bangladesh is the 62nd country to authorize the use of Sputnik V. The countries where Sputnik V has been approved altogether have a total population of some 3.2 billion people, it said.